Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

A Phase 1/2A trial of idroxioleic acid: First-in-class sphingolipid regulator and glioma cell autophagy inducer with antitumor activity in refractory glioma

Lookup NU author(s): Julieann Sludden, Professor Gareth VealORCiD, Professor Ruth PlummerORCiD

Downloads

Licence

This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0).

Publication metadata

Author(s): Lopez J, Lai-Kwon J, Molife R, Welsh L, Tunariu N, Roda D, Fernandez-Garcia P, Lladó V, McNicholl A, Roselló C, Taylor R, Azaro A, Ahnert JR, Sludden J, Veal G, Plummer R, Urruticoechea A, Lahuerta A, Mujika K, Escriba P

Publication type: Article

Publication status: Published

Journal: British Journal of Cancer

Year: 2023

Volume: 129

Pages: 811-818

Print publication date: 21/09/2023

Online publication date: 14/07/2023

Acceptance date: 01/06/2023

Date deposited: 19/09/2023

ISSN (print): 0007-0920

ISSN (electronic): 1532-1827

Publisher: Nature

URL: https://doi.org/10.1038/s41416-023-02356-1

DOI: 10.1038/s41416-023-02356-1

Altmetrics

Altmetrics provided by Altmetric

Funding

Funder referenceFunder name
CRUK
H2020 Framework Programmes
NHS England

Share